Share
𝕏 Facebook LinkedIn

Electromagnetic fields induce neural differentiation of human bone marrow derived mesenchymal stem cells via ROS mediated EGFR activation.

PAPER pubmed Neurochemistry international 2013 In vitro study Effect: benefit Evidence: Low

Abstract

Even though the inducing effect of electromagnetic fields (EMF) on the neural differentiation of human bone marrow mesenchymal stem cells (hBM-MSCs) is a distinctive, the underlying mechanism of differentiation remains unclear. To find out the signaling pathways involved in the neural differentiation of BM-MSCs by EMF, we examined the CREB phosphorylation and Akt or ERK activation as an upstream of CREB. In hBM-MSCs treated with ELF-EMF (50 Hz, 1 mT), the expression of neural markers such as NF-L, MAP2, and NeuroD1 increased at 6 days and phosphorylation of Akt and CREB but not ERK increased at 90 min in BM-MSCs. Moreover, EMF increased phosphorylation of epidermal growth factor receptor (EGFR) as an upstream receptor tyrosine kinase of PI3K/Akt at 90 min. It has been well documented that ELF-MF exposure may alter cellular processes by increasing intracellular reactive oxygen species (ROS) concentrations. Thus, we examined EMF-induced ROS production in BM-MSCs. Moreover, pretreatment with a ROS scavenger, N-acetylcystein, and an EGFR inhibitor, AG-1478, prevented the phosphorylation of EGFR and downstream molecules. These results suggest that EMF induce neural differentiation through activation of EGFR signaling and mild generation of ROS.

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
benefit
Population
Human bone marrow-derived mesenchymal stem cells (hBM-MSCs)
Sample size
—
Exposure
ELF · 0.05 MHz · 90 min (signaling endpoints); 6 days (neural marker expression)
Evidence strength
Low
Confidence: 78% · Peer-reviewed: yes

Main findings

In hBM-MSCs exposed to ELF-EMF (50 Hz, 1 mT), neural markers (NF-L, MAP2, NeuroD1) increased at 6 days. Akt and CREB phosphorylation increased at 90 min while ERK did not; EGFR phosphorylation increased at 90 min, and pretreatment with N-acetylcysteine or the EGFR inhibitor AG-1478 prevented EGFR and downstream phosphorylation, consistent with ROS-mediated EGFR signaling involvement.

Outcomes measured

  • Neural differentiation markers (NF-L, MAP2, NeuroD1)
  • Akt phosphorylation
  • CREB phosphorylation
  • ERK activation
  • EGFR phosphorylation
  • Reactive oxygen species (ROS) production
  • Effects of N-acetylcysteine (ROS scavenger) and AG-1478 (EGFR inhibitor) on signaling

Limitations

  • In vitro study; findings may not translate to in vivo or clinical outcomes
  • Sample size not reported in the provided abstract
  • Exposure conditions limited to 50 Hz, 1 mT; generalizability to other field strengths/frequencies unclear
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": "ELF",
        "source": null,
        "frequency_mhz": 0.05000000000000000277555756156289135105907917022705078125,
        "sar_wkg": null,
        "duration": "90 min (signaling endpoints); 6 days (neural marker expression)"
    },
    "population": "Human bone marrow-derived mesenchymal stem cells (hBM-MSCs)",
    "sample_size": null,
    "outcomes": [
        "Neural differentiation markers (NF-L, MAP2, NeuroD1)",
        "Akt phosphorylation",
        "CREB phosphorylation",
        "ERK activation",
        "EGFR phosphorylation",
        "Reactive oxygen species (ROS) production",
        "Effects of N-acetylcysteine (ROS scavenger) and AG-1478 (EGFR inhibitor) on signaling"
    ],
    "main_findings": "In hBM-MSCs exposed to ELF-EMF (50 Hz, 1 mT), neural markers (NF-L, MAP2, NeuroD1) increased at 6 days. Akt and CREB phosphorylation increased at 90 min while ERK did not; EGFR phosphorylation increased at 90 min, and pretreatment with N-acetylcysteine or the EGFR inhibitor AG-1478 prevented EGFR and downstream phosphorylation, consistent with ROS-mediated EGFR signaling involvement.",
    "effect_direction": "benefit",
    "limitations": [
        "In vitro study; findings may not translate to in vivo or clinical outcomes",
        "Sample size not reported in the provided abstract",
        "Exposure conditions limited to 50 Hz, 1 mT; generalizability to other field strengths/frequencies unclear"
    ],
    "evidence_strength": "low",
    "confidence": 0.7800000000000000266453525910037569701671600341796875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "ELF-EMF",
        "50 Hz",
        "1 mT",
        "mesenchymal stem cells",
        "neural differentiation",
        "ROS",
        "EGFR",
        "PI3K/Akt",
        "CREB",
        "NF-L",
        "MAP2",
        "NeuroD1",
        "N-acetylcysteine",
        "AG-1478"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.